Suppr超能文献

在老年精神分裂症患者中,没有神经病理学证据表明阿尔茨海默病的发病率增加。

No neuropathologic evidence for an increased frequency of Alzheimer's disease among elderly schizophrenics.

作者信息

Murphy G M, Lim K O, Wieneke M, Ellis W G, Forno L S, Hoff A L, Nordahl T

机构信息

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, California 94305-5485, USA.

出版信息

Biol Psychiatry. 1998 Feb 1;43(3):205-9. doi: 10.1016/S0006-3223(97)00031-0.

Abstract

BACKGROUND

There is currently controversy as to the frequency of Alzheimer's disease (AD) in elderly persons with schizophrenia. Several studies have reported an increased frequency of AD in elderly schizophrenics, whereas others have found no increase. This issue is important because it has been hypothesized that medications used to treat schizophrenia may exacerbate AD histopathology.

METHODS

We examined autopsy cases from a state psychiatric hospital and a Veterans Affairs medical center. Charts were reviewed on 166 subjects to determine if the history warranted a DSM-IV diagnosis of schizophrenia. All subjects had complete gross and microscopic neuropathologic evaluations, which were reviewed for evidence of Alzheimer's disease.

RESULTS

Retrospective chart review identified 51 subjects over the age of 55 who met DSM-IV criteria for schizophrenia (mean age = 71.7 years, SD = 8.6, range 56-95 years). Of these 51, only I met neuropathologic criteria for AD, a frequency of 2%.

CONCLUSIONS

The frequency of subjects meeting neuropathologic criteria for Alzheimer's disease in our sample of schizophrenics was equal to or less than that found in the general population. Because institutionalized populations may contain an excess of elderly schizophrenic patients with severe behavioral pathologies, which may in turn reflect the presence of neurodegenerative processes such as Alzheimer's disease, our results may actually overestimate the frequency of Alzheimer's in the entire schizophrenic population. The frequency of Alzheimer's disease in the elderly with schizophrenia may be less than that in the general population.

摘要

背景

目前,关于精神分裂症老年患者中阿尔茨海默病(AD)的发病率存在争议。多项研究报告称老年精神分裂症患者中AD发病率增加,而其他研究则未发现增加。这个问题很重要,因为据推测,用于治疗精神分裂症的药物可能会加剧AD的组织病理学变化。

方法

我们检查了一家州立精神病医院和一家退伍军人事务医疗中心的尸检病例。查阅了166名受试者的病历,以确定其病史是否符合精神分裂症的DSM-IV诊断标准。所有受试者均进行了完整的大体和显微镜神经病理学评估,并对AD证据进行了复查。

结果

回顾性病历审查确定了51名年龄超过55岁且符合精神分裂症DSM-IV标准的受试者(平均年龄 = 71.7岁,标准差 = 8.6,范围56 - 95岁)。在这51名受试者中,只有1名符合AD的神经病理学标准,发病率为2%。

结论

在我们的精神分裂症样本中,符合阿尔茨海默病神经病理学标准的受试者频率等于或低于一般人群。由于机构化人群中可能有过多患有严重行为病理学的老年精神分裂症患者,这可能反过来反映了诸如阿尔茨海默病等神经退行性过程的存在,我们的结果实际上可能高估了整个精神分裂症人群中阿尔茨海默病的频率。老年精神分裂症患者中阿尔茨海默病的频率可能低于一般人群。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验